A recent publication led by corresponding author Neda Laiteerapong exploring the implementation of population-level portal-based depression and anxiety screening for people with HIV was chosen as the second TC CFAR Directors’ Choice for 2024.
Mustanski, professor of medical social sciences at the Feinberg School of Medicine, will focus on social and behavioral sciences.
Public Health Boot Camp is an intensive one-week educational program provided by the AIDS Foundation Chicago and the Institute for Public Health and Medicine at the Northwestern University Feinberg School of Medicine.
The first TC CFAR Directors' Choice publication selected for 2024, “Analysis of the Contribution of 6-mer Seed Toxicity to HIV-1-Induced Cytopathicity,” was recently published in the Journal of Virology.
Jessica Ridgway, MD, MS, at the University of Chicago, is now the director of the CS Core, and Jennifer Jao, MD, MPH, at Northwestern University and Lurie Children’s Hospital, is the co-director for pediatrics and metabolism of the CS Core.
Four children who acquired HIV in utero have remained free of detectable HIV for more than one year, according to new findings that were presented during the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. The study is part of ongoing, multinational research led in part by Drs. Ellen Chadwick and Jennifer Jao.
Third Coast CFAR Developmental Core Co-Director, Elena Martinelli, PhD, and her research team have discovered how blocking an immune cell singling pathway in a model of HIV-1 infection may boost immune responses and decrease viral persistence in combination with antiretroviral therapy.
Jessica Ridgway, MD, MS, was recently awarded a research grant from the National Institute of Mental Health to utilize clinical phenotyping and better predict which patients living with HIV are most likely to discontinue HIV care.
A partner of the Third Coast Center for AIDS Research (TC CFAR), the Chicago Center for HIV Elimination (CCHE) at the University of Chicago has released its 2023 Annual Report showcasing CCHE's innovative research and services.
The best and most consequential original HIV research defined the science at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI).